Torleif Science ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 16.2% 12.6% 6.5% 10.9%  
Credit score (0-100)  0 10 18 35 22  
Credit rating  N/A BB BB BBB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  0.0 757 1,872 1,246 2,445  
EBITDA  0.0 186 1,053 38.4 842  
EBIT  0.0 186 1,053 38.4 842  
Pre-tax profit (PTP)  0.0 183.5 1,048.9 36.8 821.3  
Net earnings  0.0 144.5 818.1 27.9 640.3  
Pre-tax profit without non-rec. items  0.0 183 1,049 36.8 821  

 
See the entire income statement

Balance sheet (kDKK) 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 185 1,003 531 1,171  
Interest-bearing liabilities  0.0 0.0 0.0 1.5 13.3  
Balance sheet total (assets)  0.0 294 1,295 651 1,509  

Net Debt  0.0 -56.3 -1,203 -459 -1,480  
 
See the entire balance sheet

Volume 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 757 1,872 1,246 2,445  
Gross profit growth  0.0% 0.0% 147.3% -33.5% 96.3%  
Employees  0 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 294 1,295 651 1,509  
Balance sheet change%  0.0% 0.0% 340.1% -49.7% 131.6%  
Added value  0.0 185.6 1,053.1 38.4 842.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 4.0  

Profitability 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 24.5% 56.3% 3.1% 34.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 63.1% 132.6% 3.9% 78.0%  
ROI %  0.0% 100.6% 177.4% 5.0% 98.1%  
ROE %  0.0% 78.3% 137.8% 3.6% 75.3%  

Solidity 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  0.0% 62.7% 77.5% 81.4% 77.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -30.3% -114.2% -1,196.4% -175.7%  
Gearing %  0.0% 0.0% 0.0% 0.3% 1.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 168,160.0% 208.1% 282.0%  

Liquidity 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.0 2.7 4.4 5.4 4.5  
Current Ratio  0.0 2.7 4.4 5.4 4.5  
Cash and cash equivalent  0.0 56.3 1,202.5 460.8 1,492.8  

Capital use efficiency 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 184.5 1,002.6 530.5 1,170.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 186 1,053 38 842  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 186 1,053 38 842  
EBIT / employee  0 186 1,053 38 842  
Net earnings / employee  0 145 818 28 640